The utility of dried blood spots for proteomic studies: Looking forward to looking back

Proteomics - Clinical Applications

Volumn 8, Issue 11-12, 2014, Pages 896-900

  Ignjatovic, Vera ^a,b   Pitt, James ^b,c   Monagle, Paul ^b,c   Craig, Jeffrey M ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Disease prevention; Dried blood spots

Indexed keywords

BIOLOGICAL MARKER; PROTEOME; BIOLOGICAL MARKERS; BLOOD PROTEINS;

ADULT DISEASE; DRIED BLOOD SPOT TESTING; EPIGENETICS; HUMAN; MASS SCREENING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MONITORING; MULTIPLE REACTION MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; ADULT; BLOOD; BLOOD SPECIMEN COLLECTION; HUMANS; INFANT, NEWBORN; METABOLISM; METHODS; REPRODUCIBILITY OF RESULTS; TRENDS;

ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; BLOOD SPECIMEN COLLECTION; DRIED BLOOD SPOT TESTING; HUMANS; INFANT, NEWBORN; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS;

EID: 84912524708     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400042     Document Type: Review

References (38)

1. Anderson, L., Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 2005, 563, 23-60.
2. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
3. Wasinger, V. C., Zeng, M., Yau, Y., Current status and advances in quantitative proteomics mass spectrometry. Int. J. Proteom. 2013, 2013, 180605.
4. Bignami, E. L., Crescenzi, G., Gonfalini, M., Bruno, G. et al., Role of cardiac biomarkers (troponin I and CK-MB) as predictors of quality of life and long-term outcome after cardiac surgery. Ann. Card. Anaesth. 2009, 12, 22-26.
5. Opstal-van Winden, A. W., Krop, E. J. M., Kåredal, M. H., Gast, M. C. W. et al., Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum: a nested case-control study. BMC Cancer 2011, 11, 381-391.
6. Barker, D. J., Osmond, C., Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986, 1, 1077-1081.
7. Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. et al., Weight in infancy and death from ischaemic heart disease. Lancet 1989, 2, 577-580.
8. Barker, D. J., Gluckman, P. D., Godfrey, K. M., Harding, J. E. et al., Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341, 938-941.
9. Hales, C. N., Barker, D. J., Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992, 35, 595-601.
10. Rakyan, V. K., Beyan, H., Down, T. A., Hawa, M. I. et al., Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet. 2011, 7, e1002300.
11. Rakyan, V. K., Down, T. A., Balding, D. J., Beck, S., Epigenome-wide association studies for common human diseases. Nat. Rev. Genet. 2011, 12, 529-541.
12. Toperoff, G. D., Aran, D., Kark, J. D., Rosenberg, M. et al., Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum. Mol. Genet. 2012, 21, 371-383.
13. Joubert, B. R., Håberg, S. E., Nilsen, R. M., Wang, X. et al., 450K Epigenome-wide scan identifies differential dna methylation in newborns related to maternal smoking during pregnancy. Environ. Health Perspect. 2012, 120, 1425-1431.
14. Godfrey, K. M., Sheppard, A., Gluckman, P. D., Lillycrop, K. A. et al., Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011, 60, 1528-1534.
15. Martino, D., Loke, Y. J., Gordon, L., Ollikainen, M. et al., Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance. Genome. Biol. 2013, 14, R42.
16. Beyan, H., Down, T. A., Ramagopalan, S. V., Uvebrant, K. et al., Guthrie card methylomics identifies temporally stable epialleles that are present at birth in humans. Genome. Res. 2012, 22, 2138-2145.
17. Hollegaard, M. V., Grauholm, J., Nørgaard-Pedersen, B., Hougaard, D. M., Grauholm, J., DNA methylome profiling using neonatal dried blood spot samples: a proof-of-principle study. Mol. Genet. Metab. 2012, 108, 225-231.
18. Joo, J. E., Wong, E. M., Baglietto, L., Jung, C. H. et al., The use of DNA from archival dried blood spots with the Infinium HumanMethylation450 array. BMC. Biotechnol. 2013, 13, 23.
19. Cruickshank, M. N., Pitt, J., Craig, J. M., Going back to the future with Guthrie-powered epigenome-wide association studies. Genome Med. 2012, 4, 83.
20. de Vries, R., Barfield, M., van de Merbel, N., Schmid, B. et al., The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium. Bioanalysis 2013, 5, 2147-2160.
21. Carchon, H. A., Nsibu Ndosimao, C., Van Aerschot, S., Jaeken, J., Use of serum on Guthrie cards in screening for congenital disorders of glycosylation. Clin. Chem. 2006, 52, 774-775.
22. Zurfluh, M. R., Giovannini, M., Fiori, L., Fiege, B. et al., Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol. Genet. Metab. 2005, 86, S96-103.
23. Hachani, J., Duban-Deweer, S., Pottiez, G., Renom, G. et al., MALDI-TOF MS profiling as the first-tier screen for sickle cell disease in neonates: matching throughput to objectives. Prot. Clin. Appl. 2011, 5, 405-414.
24. Fredriksson, S., Gullberg, M., Jarvius, J., Olsson, C. et al., Protein detection using proximity-dependent DNA ligation assays. Nat. Biotech. 2002, 20, 473-477.
25. Gullberg, M., Gustafsdottir, S. M., Schallmeiner, E., Jarvius, J., Bjarnegard, M. et al., Cytokine detection by antibody-based proximity ligation. Proc. Natl. Acad. Sci. USA 2004, 101, 8420-8424.
26. Assarsson, E., Lundberg, M., Holmquist, G., Bjorkesten, J., Bucht Thorsen, S. et al., Homogenous 96-Plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS One 2014, 9, e95192.
27. Chambers, A. G., Percy, A. J., Yang, J., Camenzind, A. G., Borchers, C. H., Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometery. Mol. Cell. Proteomics 2013, 12, 781-791.
28. Chambers, A. G., Percy, A. J., Hardie, D. B., Borchers, C. H. Comparison of proteins in whole blood and dried blood spot samples by LC/MS/MS. J. Am. Soc. Mass. Spec. 2013, 24, 1338-1345.
29. Martin, N. J., Bunch, J., Cooper, H. J., Dried blood spot proteomics: surface extraction of endogenous proteins coupled with automated sample preparation and mass spectrometry analysis. J. Am. Soc. Mass. Spectrom. 2013, 24, 1242-1249.
30. Cui, W., Rohrs, H. W., Gross, M. L., Top-down mass spectrometry: Recent developments, applications and perspectives. Analyst 2011, 136, 3854-3864.
31. Van Berkel, G. J., Kertesz, V., Koeplinger, K. A., Vavrek, M., Kong, A.-N. T., Liquid microjunction surface sampling probe electrospray mass spectrometry for detection of drugs and metabolites in thin tissue sections. J. Mass Spectrom. 2008, 43, 500-508.
32. Edwards, R. L., Creese, A. J., Baumert, M., Griffiths, P. et al., Hemoglobin variant analysis via direct surface sampling of dried blood spots coupled with high-resolution mass spectrometry. Anal. Chem. 2011, 83, 2265-2270.
33. Edwards R. L., Griffiths, P., Bunch, J., Cooper, H. J., Top-down proteomics and direct surface sampling of neonatal dried blood spots: diagnosis of unknown haemoglobin variants. J. Am. Soc. Mass Spectrom. 2012, 23, 1921-1930.
34. Matsuda, K. C., Hall, C., Baker-Lee, C., Soto, M., Scott, G. et al. Measurement of in vivo therapeutic mAb concentrations: comparison of conventional serum/plasma collection and analysis to dried blood spot sampling. Bioanalysis 2013, 5, 1979-1990.
35. Jang, W., Mao, Y. Q., Huang, R., Duan, C. et al., Protein expression profiling by antibody array analysis with use of dried blood spot samples on filter paper. J. Immunol. Meth. 2014, 403, 79-86.
36. Gardner, R. M., Dalman, C., Wicks, S., Lee, B. K., Karlsson, H., Neonatal levels of acute phase proteins and later risk of non-affective psychosis. Transl. Psychiatry 2013, 3, e228.
37. Botkin, J. R., Goldenberg, A. J., Rothwell, E., Anderson, R. A., Lewis, M. H. Retention and research use of residual newborn screening bloodspots. Pediatrics 2013, 131, 120-127.
38. Lewis, M. H., Goldenberg, A., Anderson, R., Rothwell, E., Botkin, J., State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics 2011, 127, 703-712.